Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10878964 | 0.92 | TSHR (0.39) | TSHRLMNATHRB | |
| SCHEMBL8764126 | 0.89 | TSHR (0.42) | TSHRLMNATHRBALDH1A1 | |
| SCHEMBL725791 | 0.81 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL10731666 | 0.75 | TSHR (0.38) | TSHRLMNATHRBALDH1A1 | |
| SCHEMBL4630251 | 0.74 | — | — | |
| SCHEMBL10725699 | 0.71 | TSHR (0.33) | TSHRLMNATHRB | |
| SCHEMBL16414463 | 0.71 | TSHR (0.33) | TSHRLMNATHRB | |
| SCHEMBL20658198 | 0.71 | TSHR (0.33) | TSHRLMNATHRB | |
| SCHEMBL9504255 | 0.69 | TSHR (0.32) | TSHRLMNATHRB | |
| SCHEMBL725792 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017102055-A1 | METHOD FOR PRODUCING SALTS WITH MONOFLUOROTRICYANOBORATE ANIONS | MERCK PATENT GMBH (DE) | 2017-06-22 | — | — | WO | disclosed |
| EP-2731955-B1 | COMPOUNDS CONTAINING ALKYL-CYANO-BORATE OR ALKYL-CYANO-FLUOROBORATE ANIONS | MERCK PATENT GMBH (DE) | 2017-01-11 | — | — | EP | disclosed |
| US-9399650-B2 | Method for producing salts having monofluoro-tricyanoborate anions | MERCK PATENT GMBH (DE) | 2016-07-26 | — | — | US | disclosed |
| WO-2016074760-A1 | METHOD FOR PRODUCING SALTS HAVING HYDRIDOCYANOBORATE ANIONS | MERCK PATENT GMBH (DE) | 2016-05-19 | — | — | WO | disclosed |
| US-20160130285-A1 | METHOD FOR PRODUCING SALTS HAVING HYDRIDOCYANOBORATE ANIONS | MERCK PATENT GMBH (DE) | 2016-05-12 | — | — | US | disclosed |
| US-20160130286-A1 | METHOD FOR PRODUCING SALTS HAVING MONOFLUORO-TRICYANOBORATE ANIONS | MERCK PATENT GMBH (DE) | 2016-05-12 | — | — | US | disclosed |
| EP-3008074-A1 | METHOD FOR PRODUCING SALTS HAVING HYDRIDOCYANOBORATE ANIONS | Merck Patent GmbH (DE) | 2016-04-20 | — | — | EP | disclosed |
| EP-3008075-A1 | METHOD FOR PRODUCING SALTS HAVING MONOFLUORO-TRICYANOBORATE ANIONS | Merck Patent GmbH (DE) | 2016-04-20 | — | — | EP | disclosed |
| WO-2016015811-A1 | METHOD FOR PRODUCING SALTS HAVING HYDRIDOCYANOBORATE ANIONS | MERCK PATENT GMBH (DE) | 2016-02-04 | — | — | WO | disclosed |
| WO-2015185178-A1 | METHOD FOR PREPARING TETRACYANOBORATE SALTS | MERCK PATENT GMBH (DE) | 2015-12-10 | — | — | WO | disclosed |
| WO-2013010641-A1 | COMPOUNDS CONTAINING ALKYL-CYANO-BORATE OR ALKYL-CYANO-FLUOROBORATE ANIONS | MERCK PATENT GMBH (DE) | 2013-01-24 | — | — | WO | disclosed |
| US-20120309982-A1 | ELECTROLYTE FORMULATIONS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-12-06 | — | — | US | disclosed |
| US-20120309981-A1 | PROCESS FOR THE PREPARATION OF PERFLUOROALKYLCYANO- OR PERFLUOROALKYLCYANOFLUOROBORATES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-12-06 | — | — | US | disclosed |
| WO-2012163488-A1 | PROCESS FOR PREPARING DIHYDRIDODICYANOBORATE SALTS | MERCK PATENT GMBH (DE) | 2012-12-06 | — | — | WO | disclosed |
| WO-2012163490-A1 | ELECTROLYTE FORMULATIONS | MERCK PATENT GMBH (DE) | 2012-12-06 | — | — | WO | disclosed |
| US-20120296096-A1 | COMPOUNDS CONTAINING PERFLUOROALKYL-CYANO-ALKOXY-BORATE ANIONS OR PERFLUOROALKYL-CYANO-ALKOXY-FLUORO-BORATE ANIONS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-11-22 | — | — | US | disclosed |
| WO-2012041434-A1 | ELECTROLYTE FORMULATIONS CONTAINING CYANO-ALKOXY-BORATE ANIONS | MERCK PATENT GMBH (DE) | 2012-04-05 | — | — | WO | disclosed |
| WO-2011085965-A1 | ELECTROLYTE FORMULATIONS | MERCK PATENT GMBH (DE) | 2011-07-21 | — | — | WO | disclosed |
| WO-2011085966-A1 | METHOD FOR PRODUCING PERFLUOROALKYL CYANOBORATES OR PERFLUOROALKYL CYANOFLUOROBORATES | MERCK PATENT GMBH (DE) | 2011-07-21 | — | — | WO | disclosed |
| WO-2011085967-A1 | COMPOUNDS CONTAINING PERFLUOROALKYL-CYANO-ALKOXY-BORATE ANIONS OR PERFLUOROALKYL-CYANO-ALKOXY-FLUORO-BORATE ANIONS | MERCK PATENT GMBH (DE) | 2011-07-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160130286-A1 | METHOD FOR PRODUCING SALTS HAVING MONOFLUORO-TRICYANOBORATE ANIONS | SLC6A6, TBCB, CA6 | TSHR 2937/4885LMNA 2824/4885THRB 3159/4885 |
| US-20120309982-A1 | ELECTROLYTE FORMULATIONS | SLC9A5, NHERF1, AFF1 | TSHR 1226/4885LMNA 3066/4885THRB 3371/4885 |
| US-20120296096-A1 | COMPOUNDS CONTAINING PERFLUOROALKYL-CYANO-ALKOXY-BORATE ANIONS OR PERFLUOROALKYL-CYANO-ALKOXY-FLUORO-BORATE ANIONS | PFAS, PFKFB3, PFKFB1 | TSHR 1427/4885LMNA 863/4885THRB 2050/4885 |
| US-20120309981-A1 | PROCESS FOR THE PREPARATION OF PERFLUOROALKYLCYANO- OR PERFLUOROALKYLCYANOFLUOROBORATES | SLCO4C1, SLCO2B1, PFAS | TSHR 731/4885LMNA 1434/4885THRB 1999/4885 |
| US-20160130285-A1 | METHOD FOR PRODUCING SALTS HAVING HYDRIDOCYANOBORATE ANIONS | HDHD5, SLC6A6, MAGT1 | TSHR 2549/4885LMNA 4369/4885THRB 2774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.